AnaCardio
AnaCardio is a privately held clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
Visit websiteStockholm, Sweden
Healthtech
Funding summary
- Total raised
- €14.1M
- Funding rounds
- 1
Investors in AnaCardio
Investors on record for AnaCardio. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like AnaCardio?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors